Skip to content

To see the effect of chandanadi bidalaka in pittaj abhishyanda that is conjunctivitis

Single arm clinical study to evaluate the efficacy of chandanadi bidalaka in pittaj abhishyanda with special reference to acute mucopurulent conjunctivitis. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070795
Enrollment
40
Registered
2024-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H100- Mucopurulent conjunctivitis

Interventions

None listed

Sponsors

Dr Sayali Tarachand Rathod
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients showing the classical sign and symptoms of Pittaj Netra Abhishyanda will be selected for the study. 2. Patients of age group above 10 years and below 50 yrs. Will be selected for the study. 3. Patients irrespective of sex, occupation and socio-economic status will be selected.

Exclusion criteria

Exclusion criteria: 1. Patients of age group below 10 years and above 50 yrs. 2. Patients with other occular disease. 3. Recently eye operated patients. 4. Patients with other major systemic diseases. 5. Using any other eye medications.

Design outcomes

Primary

MeasureTime frame
To decreases the symptomes of redness wateringTimepoint: 15 days study with follow up of 3rd,5th,7th and 15th day (0,3,5,7,15)

Secondary

MeasureTime frame
To study the effect of ayurvedic formulationTimepoint: 15 day study with follow up of 3rd,5th,7th,15th.(0,3,5,7,15)

Countries

India

Contacts

Public ContactDr Sayali Tarachand Rathod

LRP AYURVEDIC COLLEGE AND HOSPITAL PG INSTITUTE AND RESEARCH CENTRE,URUN ISLAMPUR

drneetapatil@rediffmail.com9527525654

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026